Richard W. Dugan, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 11,508 shares at $18.54 ($213K) on 2021-02-16, disclosed to the SEC on 2021-02-18.
Open-market sale of $213k VNDA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.54 | 5,754 | $107K | 50.0% |
| 2 | $18.54 | 5,754 | $107K | 50.0% |
| Total | $18.54 avg | 11,508 | $213K | 100% |
| Filing → |
| VNDA | SELL | 2019-08-28 | $223K | — | Filing → |
| VNDA | SELL | 2015-03-10 | $51K | — | Filing → |